Rob J. Lieverse

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 334 citations

Terminal Ileitis, Gastroenterology, Multicentre Trial +4

Satiety effects of a physiological dose of cholecystokinin in humans.

Rob J. Lieverse, Jan B.�M.�J. Jansen, Ad Masclee et al. · Gut · 1995 · 180 citations · Full text

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 173 citations

Terminal Ileitis, Medicine, C Trial +5

Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Rob J. Lieverse, J.B.M.J. Jansen, Ad Masclee et al. · Gut · 1994 · 109 citations · Full text

Satiety effects of cholecystokinin in humans

Rob J. Lieverse, Jan B.�M.�J. Jansen, Ad Masclee et al. · Gastroenterology · 1994 · 95 citations

Nutrition, Biliary Tract, Medicine +7